Aardvark Therapeutics
Rethinking Metabolic Health
Aardvark Therapeutics was founded in 2017, is headquartered in San Diego, United States, lists 11–50 employees, and has $114.0M in recorded funding across 2 rounds.
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- aardvarktherapeutics.com
- Total Funding
- $114.0M
- Last Round
- $85.0M Series CMay 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 11 investors for this company. The full record is or through the API.
About
Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and treat metabolic diseases. Its lead compound, ARD-101, is an oral investigational drug that activates bitter taste receptors (TAS2Rs) in the digestive tract to trigger the local release of satiety hormones and suppress hunger. The company is focused on conditions including hyperphagia in rare diseases such as Prader-Willi Syndrome as well as general obesity, with the goal of becoming a leader in the treatment of hunger-associated metabolic disorders.
Summary
Aardvark Therapeutics is a Biotech company based in San Diego, United States, founded in 2017. It lists 11–50 employees. It has raised $114.0M in total across 2 rounds, most recently a $85.0M Series C round in May 2024. Investors include Decheng Capital, Cormorant Asset Management and Surveyor Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2024
Sign up to see all 2 events
Funding: Series B through Series C. Amounts, valuations, and investors where available.
Investors
Decheng Capital
1 round
Cormorant Asset Management
1 round
Surveyor Capital
1 round
SymBiosis II
1 round
Tetragon Financial Group
1 round
Laurion Capital Management
1 round
LG Technology Ventures
1 round
Vickers Venture Partners
1 round
Premier Inc.
1 round
BNH Investment
1 round
Korea Omega Investment Corp
1 round
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aardvark-therapeutics"><img src="https://indexed.vc/api/badge/company/aardvark-therapeutics" alt="Aardvark Therapeutics on Indexed.vc" width="260" height="76" /></a>